UnknownNot applicableNCT04881214

COVID-19 Pneumonia: Pulmonary Physiology, Health-related Quality of Life and Benefit of a Rehabilitation Program

Studying Chronic thromboembolic pulmonary hypertension

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Geneva
Principal Investigator
Lador Frédéric, MD-PHD
University Hospital, Geneva
Intervention
Pulmonary rehabilitation(other)
Enrollment
60 enrolled
Eligibility
18 years · All sexes
Timeline
20202023

Study locations (1)

Collaborators

Ligue Pulmonaire Genevoise

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04881214 on ClinicalTrials.gov

Other trials for Chronic thromboembolic pulmonary hypertension

Additional recruiting or active studies for the same condition.

See all trials for Chronic thromboembolic pulmonary hypertension

← Back to all trials